PGNY NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Progyny Inc · Healthcare · Healthcare Plans

Open interactive chart View report data Download investor PDF
Latest close 31.19 USD
-2.3% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 34.6% above the Trend Line and sits at 88.9% of its 52-week range. The latest completed week returned -2.3%, after a 9.4% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is expensive relative to peers. Options positioning is volatility with 57/100 conviction, while the latest news-sentiment score is 57/100. Near-term considerations: volume confirmation is below normal; earnings are due in 7d.

Setup score 61 out of 100
Latest Close 31.19 USD 24 Jul 2026
1W Return -2.3% latest completed week
4W Return 9.4% short-term follow-through
12W Return 67.7% quarterly tape
Trend Breadth 44.2% 23 of 52 weeks active
Volume Ratio 0.6x vs 13-week average
What is working
  • The trend backdrop is active with a 4-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • No major top-level risk cluster is currently dominant.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -2.3% Latest completed week; four-week move 9.4%. Indicator stack 38/69 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 57/100 conviction; expected move 15.0%. News sentiment 57/100 53 relevant articles in the latest sentiment read. Event risk 7d Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 34.6% above the Trend Line and sits at 88.9% of its 52-week range. The latest completed week returned -2.3%, after a 9.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8112-week average 0.45

12-week confirmation

Trend active4/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership7/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.81Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 9.4% over four weeks, 67.7% over 12 weeks, and 35.0% over one year. The current trend has remained active for 4 consecutive weeks.

Performance by holding period

1W-2.3%
4W9.4%
12W67.7%
26W23.7%
52W35.0%
Active trend streak4 weeks
Active weeks in one year23
Trend breadth44.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.02Latest activity-pressure read.
Pressure change6.2%Four-week change in activity pressure.
Leadership24.38Latest relative-leadership reading.
RS change122.0%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength54/100Blend of value, momentum, and quality. Underlying universe rank 47; rank 1 is best.
Value21/100Relative valuation strength. Underlying universe rank 80; rank 1 is best.
Quality85/100Profitability and accounting quality. Underlying universe rank 16; rank 1 is best.
Momentum76/100Medium-term price momentum. Underlying universe rank 25; rank 1 is best.
Growth35/100Revenue and earnings growth. Underlying universe rank 66; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework50/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
36.1x
Price divided by trailing earnings.
Price / sales
1.9x
Market value relative to trailing revenue.
EV / EBITDA
21.0x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
9.8%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
24.1%
Gross profit retained from each unit of revenue.
Operating margin
8.2%
Operating profit retained from revenue.
Free-cash-flow margin
17.7%
Free cash flow generated from revenue.
Return on invested capital
20.3%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
6.6%
Latest one-year revenue growth.
EPS growth
28.9%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
8.4%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
8.1%
Net share repurchases relative to market value.
Shareholder yield
8.1%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.9x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

PGNY shows volatility options pressure with a 57/100 conviction score, put-call volume ratio of 18.08, expected move of 15.0%, and Sharemaestro trend signal active.

Conviction57/100
Expected move15.0%
Put/call volume18.08
Pressure-80
Speculation42
Volatility95
Trend agreement18
Open options detail
Insider activity1 / 19

1 acquisitions and 19 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment57/100

Weighted news tone is neutral across 53 relevant articles.

23 positive · 26 neutral · 4 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings7dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move15.0%Nearest-chain priced movement where available.
52-week drawdown-5.7%Distance below the 52-week high.
13-week volatility7.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+27.5%Week of 8 May.
Worst week-15.7%Week of 27 Feb.
Latest week-2.3%Week of 24 Jul.

Shape of recent returns

Strong gains6
Modest gains9
Flat weeks0
Modest losses5
Sharp losses6
Recent vol7.5%13-week weekly-return volatility.
Base vol6.9%52-week weekly-return volatility.
Up/down split27/25Count of positive and negative weeks in the 52-week window.
Average skew5.4% / -4.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape55/100

Trend, activity pressure, participation, and risk combine to a 55/100 tape read.

 Indicator analysis62/100

Latest 12-week confirmation: trend 4/12, activity pressure 11/12, relative leadership 7/12.

Activity pressure 0.81; No reversal markers Factors58/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 7; Small Cap Core rank 74 SVQF50/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 364.0 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options42/100

PGNY shows volatility options pressure with a 57/100 conviction score, put-call volume ratio of 18.08, expected move of 15.0%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 15.0% Sentiment57/100

Weighted news tone is neutral across 53 relevant articles.

Progyny Shares Drop After Downgrade From Barclays Insiders1 / 19

1 acquisitions and 19 disposals in the latest 180-day insider tape.

 Earnings7d

Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202631.19 USD-2.3%23.17 USD25.69 USD1.0224.383.9MOn
17 Jul 202631.93 USD4.2%22.99 USD25.75 USD1.0125.606.0MOn
10 Jul 202630.65 USD1.4%22.81 USD25.80 USD0.9815.956.8MOn
3 Jul 202630.22 USD6.0%22.68 USD25.86 USD0.9316.415.0MOn
26 Jun 202628.51 USD9.3%22.48 USD25.90 USD0.9610.986.5MOff
19 Jun 202626.08 USD-2.1%22.41 USD25.97 USD0.92-3.037.4MOff
12 Jun 202626.63 USD3.0%22.40 USD26.04 USD0.961.406.8MOff
5 Jun 202625.86 USD1.2%22.33 USD26.12 USD0.960.587.6MOff
29 May 202625.56 USD2.7%22.21 USD26.21 USD0.98-5.295.9MOff
22 May 202624.88 USD7.0%21.98 USD26.30 USD0.66-5.488.9MOff
15 May 202623.25 USD-2.0%21.80 USD26.38 USD0.19-10.879.0MOff
8 May 202623.72 USD27.5%21.67 USD26.47 USD-0.25-9.8410.7MOff
1 May 202618.60 USD2.4%21.55 USD26.55 USD-0.83-25.817.1MOff
24 Apr 202618.17 USD0.3%21.62 USD26.65 USD-1.03-27.166.1MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.